PRO DEX INC - 10-Q Filing Summary
Business Context and Reporting Period
This summary covers the unaudited quarterly report (Form 10-Q) for PRO DEX INC for the three and nine months ended March 31, 2026. Pro-Dex specializes in the design and manufacture of surgical drivers and shavers for orthopedic, thoracic, and maxocranial facial markets. The company also manufactures rotary air motors and, following a recent acquisition, precision machined parts for aerospace and defense industries. The company operates as a single reportable segment.
Key Financial Metrics
| Metric | Three Months Ended Mar 31, 2026 | Nine Months Ended Mar 31, 2026 | Three Months Ended Mar 31, 2025 | Nine Months Ended Mar 31, 2025 |
|---|---|---|---|---|
| Net Sales | $19.95 million | $57.14 million | $17.41 million | $49.10 million |
| Gross Profit | $6.13 million | $17.24 million | $5.80 million | $16.02 million |
| Gross Margin | 31% | 30% | 33% | 33% |
| Operating Income | $3.09 million | $9.46 million | $3.64 million | $9.35 million |
| Net Income | $3.94 million | $10.81 million | $3.28 million | $7.78 million |
| Diluted EPS | $1.20 | $3.27 | $0.98 | $2.31 |
| Cash & Equivalents (End of Period) | $9.99 million (as of Mar 31, 2026) | |||
| Working Capital | ||||
| Total Debt (Notes Payable) | $18.54 million (as of Mar 31, 2026) | |||
| Revolving Credit Availability |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 15% year-over-year (YoY) for the quarter and 16% for the nine-month period. Medical device product sales drove this growth, increasing 36% for the quarter, largely due to a contract extension with the company's largest customer (who accounts for 79% of sales).
- Acquisition Impact: On February 9, 2026, Pro-Dex acquired Advanced Precision Machining (APM) for $8.65 million. This acquisition added $6.53 million in goodwill and contributed to industrial sales growth.
- Investment Gains: Net income was significantly boosted by non-operating gains. The company recorded a $2.39 million gain on equity investments in the quarter (and $5.44 million for the nine months) related to the acquisition of its investment in Monogram Technologies by Zimmer Biomet and the achievement of the first of five contingent value rights milestones.
- Margin Compression: Gross margin decreased by 2 to 3 percentage points YoY, attributed to unfavorable product mix and increased under-absorption of manufacturing costs.
- Operating Expenses: Selling, general, and administrative (SG&A) expenses increased 82% for the quarter and 38% for the nine months, driven by personnel costs, APM integration expenses, and legal fees related to the acquisition.
Guidance, Outlook, and Risks
- Backlog: As of March 31, 2026, the company reported a backlog of approximately $39.0 million, with $15.6 million scheduled for delivery in the fourth quarter of fiscal 2026.
- Outlook: Management expects similar revenue levels in orthopedic sales through 2028 due to the extended contract with its largest customer. The company is focusing on integrating APM and launching new products, including the Helios driver for CMF applications.
- Liquidity: The company holds $9.99 million in cash and has $11.0 million available under its revolving credit facility. Management believes existing resources are sufficient for the next 12 months.
- Risks:
- Customer Concentration: One customer accounted for 79% of sales and 75% of accounts receivable in the quarter ended March 31, 2026.
- Debt Covenants: The company has significant debt obligations ($18.54 million total notes payable) and must remain in compliance with financial covenants.
- Repair Revenue Decline: Repair revenue decreased 48% YoY for the quarter as customers replace legacy handpieces with newer models.
Investor Verification Checklist
- Customer Dependency: Verify the stability of the contract with the single customer representing 79% of revenue and the potential impact of their inventory management decisions.
- Non-Recurring Gains: Assess the sustainability of earnings by excluding the $2.39 million investment gain in the quarter, which significantly inflated Net Income and EPS.
- APM Integration: Monitor the integration progress of the APM acquisition and its ability to generate standalone revenue in the aerospace/defense sector.
- Debt Service: Review the terms of the new Term Loan D ($6.65 million) and the subordinated promissory note ($2.0 million) issued for the APM acquisition to ensure cash flow coverage.
- Inventory Reserves: Investigate the specific "complex machined component" reserves mentioned in the cost of sales discussion that contributed to margin pressure.